These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16100192)

  • 1. Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients.
    Spyropoulos AC
    Chest; 2005 Aug; 128(2):958-69. PubMed ID: 16100192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.
    Nutescu EA
    Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S5-13. PubMed ID: 17519445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Geerts WH; Pineo GF; Heit JA; Bergqvist D; Lassen MR; Colwell CW; Ray JG
    Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolic risk and its prevention in hospitalized medical patients.
    Haas SK
    Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboprophylaxis in medical patients: the role of low-molecular-weight heparin.
    Turpie AG; Norris TM
    Thromb Haemost; 2004 Jul; 92(1):3-12. PubMed ID: 15213839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of venous thromboembolism in hospitalized medical patients.
    Lenchus JD; Jaffer AK
    Mt Sinai J Med; 2008 Oct; 75(5):449-53. PubMed ID: 18828167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
    Brown A
    Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
    Haas S
    Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing the right heparin prophylaxis strategy in medical patients at risk for developing VTE: an evidence-based approach.
    Harrington DW
    Hosp Pract (1995); 2010 Nov; 38(4):18-28. PubMed ID: 21068523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF; Kher A
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.
    Di Nisio M; Porreca E
    Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
    Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
    J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
    Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
    Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
    Nutescu EA; Wittkowsky AK; Dobesh PP; Hawkins DW; Dager WE
    Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inadequacy of thromboprophylaxis in hospitalized medical patients].
    Rocha AT; Braga P; Ritt G; Lopes AA
    Rev Assoc Med Bras (1992); 2006; 52(6):441-6. PubMed ID: 17242783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials.
    Wein L; Wein S; Haas SJ; Shaw J; Krum H
    Arch Intern Med; 2007 Jul; 167(14):1476-86. PubMed ID: 17646601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a clinical pharmacy education program on improvement in the quantity and quality of venous thromboembolism prophylaxis for medically ill patients.
    Dobesh PP; Stacy ZA
    J Manag Care Pharm; 2005; 11(9):755-62. PubMed ID: 16300419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.